News & Events | News

December 19, 2022

Altis Biosystems Awards New Research Funding to Plakous Therapeutics, Inc.

Altis Biosystems, Inc., developer of RepliGut®, Awards New Research Funding to Plakous Therapeutics, Inc

July 13, 2022

Altis Biosystems to Award a Fully Funded Pilot Project

Altis Biosystems, Inc., developer of RepliGut®, announces a Research Funding Initiative

June 22, 2022

Assessing Drug-induced Gut Toxicity In Vitro

This webinar addresses the challenges of assessing drug-induced gut toxicity in vitro and introduces the Altis RepliGut Planar Model

May 12, 2022

Altis named one of the top 20 most innovative organ-on-a-chip companies in the world.

Top 20 most innovative organ-on-a-chip companies

February 3, 2022

Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute

Altis Biosystems, Inc., developer of RepliGut®, a technology platform that produces a layer of human intestinal stem...